Emcure Pharmaceuticals (BOM:544210) Long-Term Debt : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals Long-Term Debt?

Emcure Pharmaceuticals's Long-Term Debt for the quarter that ended in Dec. 2024 was ₹0 Mil.

Emcure Pharmaceuticals's quarterly Long-Term Debt declined from Mar. 2024 (₹7,666 Mil) to Sep. 2024 (₹2,840 Mil) and declined from Sep. 2024 (₹2,840 Mil) to Dec. 2024 (₹0 Mil).

Emcure Pharmaceuticals's annual Long-Term Debt increased from Mar. 2022 (₹7,173 Mil) to Mar. 2023 (₹7,441 Mil) and increased from Mar. 2023 (₹7,441 Mil) to Mar. 2024 (₹7,666 Mil).

Emcure Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for Emcure Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals Long-Term Debt Chart

Emcure Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

7,039.70

7,172.82

7,441.35

7,665.95

Emcure Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial			6,488.34	-	7,665.95	2,840.22	-

Emcure Pharmaceuticals (BOM:544210) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Emcure Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Emcure Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (BOM:544210) » Definitions » Long-Term Debt

Traded in Other Exchanges

EMCURE:India

Address

Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057

Website

https://www.emcure.com

Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines